Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission

ONCOLife

Artificial Sweetener Sucralose May Undermine Cancer Immunotherapy, Study Finds

ONCOLife

Global Data Warns of Secondary Cancers Linked to CAR-T Therapy, Urging Monitoring

ONCOLife

Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment

ONCOLife

Advancing ADCs and Bispecifics Across Oncology and Immunology

AI

From Code to Cure: AI-Designed Proteins Arm T Cells to Precisely Target Cancer

ONCOLife

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

ONCOLife

Promising Targeted Immunotherapy Improves Survival in HPV16+ Cancers

ONCOLife

How SkinJect’s Microneedle-Patch Could Improve Skin Cancer Treatment Outcomes

ONCOLife Issues

Featured Articles

2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research

3 August 2025

This weekend, the Pan-Mass Challenge (PMC) unites more than 6,500 riders and 3,500 volunteers for its 46th ride, with the common goal of raising $76 million to support lifesaving cancer research and treatment at Dana-Farber Cancer Institute. Last year, the PMC...

Trending Articles

Darzalex Faspro Achieves Outstanding Results in Multiple Myeloma with 95% 4-Year PFS

AI-Driven bioX Genetics Platform Slashes Genetic Variant Detection Time

Pharma

5 June 2025

AMPLITUDE: Niraparib Combo Improves rPFS in HRR-Altered mCS Prostate Cancer

ONCOLife

4 June 2025

Vividion and Bayer Advance First-in-Class WRN Inhibitor VVD-214 for Solid Tumors

Pharma

4 June 2025

IMforte Study: Tecentriq Plus Lurbinectedin Extends Survival in ES-SC Lung Cancer

ONCOLife

4 June 2025

Enhertu-pertuzumab Combo Shows 44% Risk Reduction in HER2+ Breast Cancer

FDA Approves Darolutamide Plus ADT for mCS Prostate Cancer

FDA & EMA

3 June 2025

OASIS-4 Trial: Elinzanetant Reduces Hot Flashes in Breast Cancer Treatment

ONCOLife

2 June 2025

BioNTech and BMS Forge Partnership to Advance BNT327 for Solid Tumors

Pharma

2 June 2025

Pasritamig’s Favorable Safety and Efficacy in Advanced Prostate Cancer

ONCOLife

1 June 2025

Imdelltra Extends Survival in Small Cell Lung Cancer, Cutting Death Risk by 40%

ctDNA-Guided Camizestrant Switch Redefines 1st-Line Breast Cancer Treatment

ONCOLife

1 June 2025

World-First Clinical Trial Confirms Exercise Boosts Survival in Colon Cancer

ONCOLife

1 June 2025

Libtayo Demonstrates 68% Risk Reduction in High-Risk CS Cell Carcinoma

ONCOLife

31 May 2025

Inavolisib Combination Doubles PFS in PIK3CA Mutated Advanced Breast Cancer

ONCOLife

31 May 2025